Description
Ipamorelin 10mg research peptide material is supplied for laboratory and non-clinical investigation of ipamorelin, a selective growth hormone secretagogue studied extensively in pituitary-signaling and endocrine research models.
What Is Ipamorelin
Ipamorelin is a synthetic pentapeptide that functions as a selective agonist of the growth hormone secretagogue receptor (GHS-R), distinguished by minimal off-target receptor activity compared to earlier-generation secretagogues. Ipamorelin 10mg research peptide material is used by laboratories investigating GHS-R activation, pulsatile growth-hormone release, and downstream endocrine signaling across in vitro and animal-model research systems.
Research Applications (laboratory / non-clinical research only)
- Animal model research into GHS-R activation and pituitary signaling selectivity
- In vitro studies of pulsatile growth-hormone secretion mechanisms
- Preclinical investigation of ghrelin-receptor pathway research models
- Comparative research into ipamorelin versus other growth hormone secretagogue compounds
- Laboratory studies of somatotroph cell response in the anterior pituitary
Quality & Sourcing
Ipamorelin 10mg research peptide material is manufactured to high purity standards and verified by HPLC (High-Performance Liquid Chromatography) analysis. Each batch is lyophilized for stability, and a Certificate of Analysis (COA) is available on request confirming peptide identity and purity. Material is intended for use by qualified researchers in controlled laboratory environments only.
Supplied As
Supplied as a lyophilized 10mg vial in a 3ml format, suitable for standard laboratory reconstitution procedures performed by trained personnel for research purposes.
Molecular Characteristics
Ipamorelin is a synthetic pentapeptide (5 amino acids) that functions as a selective agonist of the growth hormone secretagogue receptor, distinguished from earlier secretagogues by minimal activity at other receptors, including those associated with cortisol and prolactin release. This selectivity is generally reported in the literature as a key differentiator when researchers compare ipamorelin against older secretagogue compounds. As a short peptide chain, ipamorelin is relatively straightforward to synthesize to high purity and is generally supplied as a lyophilized powder for research use.
Handling & Storage Considerations
Lyophilized ipamorelin should be stored in a freezer (-20°C or below), protected from light and moisture, until the researcher is ready to reconstitute the material for a laboratory protocol. Once reconstituted with bacteriostatic water, the solution is generally stored refrigerated (2-8°C) and used within the window supported by internal stability testing. As with other growth-hormone secretagogue peptides, repeated freeze-thaw cycles and prolonged room-temperature exposure are generally avoided to preserve research-grade integrity.
Common Research Design Considerations
Laboratories investigating ipamorelin commonly design animal-model studies evaluating GHS-R activation and pituitary signaling selectivity, often measuring pulsatile growth-hormone release patterns in rodent models. In vitro research frequently uses pituitary cell culture systems to characterize somatotroph cell response following ipamorelin exposure. Comparative study designs often examine ipamorelin alongside other growth hormone secretagogues, such as CJC-1295, to characterize combined or comparative pathway engagement within the same research program.
Frequently Asked Questions
Is this compound stable at room temperature?
Short-term handling at room temperature during active laboratory use is generally acceptable, but frozen storage is recommended between research sessions to preserve peptide integrity.
What purity level should researchers expect?
Material is verified by HPLC analysis at the time of batch testing, with purity data available via the accompanying Certificate of Analysis.
Is a Certificate of Analysis provided?
Yes, a COA is available on request for each batch, confirming identity and purity for research documentation purposes.
Related Compounds
Researchers investigating ipamorelin often also study CJC-1295, as the two peptides are frequently examined together in growth-hormone axis research, including combination formulations such as the CJC-1295/Ipamorelin blend available in the catalog. This comparative approach helps characterize whether combined secretagogue signaling differs from single-compound receptor activation in a given experimental model. Ipamorelin is also occasionally included in broader secretagogue panels for reference comparison purposes. Researchers commonly compare ipamorelin-based protocols with other growth-hormone secretagogues such as Sermorelin Acetate and Tesamorelin when characterizing receptor-specific research outcomes.
For research use only. Not for human or veterinary use. Not a drug, supplement, or therapeutic product. Not intended to diagnose, treat, cure, or prevent any condition.
